Las nuevas pruebas de antígenos son peores que la PCR para evaluar a pacientes asintomáticos en el futuro.
One of the leading companies in the sector warns that they tend to give false negatives in people with lower amounts of virus and point out that they are only reliable in those with high viral load...
